Mental Health

Special Report By Isabella Cueto

Jolting the brain’s circuits with electricity is moving from radical to almost mainstream therapy. Some crucial hurdles remain

Don't Miss By STAT Staff

We wish we’d written that: STAT staffers share their favorite stories of 2021

First Opinion By David Introcaso

Deaths of despair: the unrecognized tragedy of working class immiseration

Health Tech By Mario Aguilar

Three missing pieces the digital therapeutics sector needs to succeed in 2022

First Opinion Podcast By Patrick Skerrett

Listen: A parent on advocating for people with autism who can’t advocate for themselves

First Opinion By Margarita Alegría

Many states aren’t ready for a 988 crisis line. The deadline is looming

Health By Maddie Bender

As a Logic song topped the charts, helpline saw more calls and fewer suicides

First Opinion By Erica Johnson

Gatekeepers need to tame ‘Wild West’ of mental health and other digital health therapeutics

Health By Theresa Gaffney

A decade without data: Eating disorder researchers say a gap in CDC survey has left them flying blind

Health By Angus Chen and Olivia Goldhill

STAT+ Conversation: The ‘Shroom Boom’

First Opinion By Gary W. Small

Stopping the spread of mass hysteria by Facebook, other social media platforms

First Opinion By Alison Singer

Labels can harm, but they also can help: See ‘profound autism’

Health Tech By Mario Aguilar

The pandemic forced an experiment in delivering intensive mental health care from home. Will the approach stick?

Eating disorders have been made worse by the pandemic

First Opinion By David A. Asch and Kelly C. Allison

The pandemic has deeply affected many people with eating disorders

Health Tech By Mario Aguilar

Talkspace’s leadership exodus leaves behind pressing questions — and a pile of cash

First Opinion By Thomas R. Insel and Andy Keller

Why is the CDC missing in action on severe mental illnesses?

Health Tech By Mario Aguilar

A telehealth effort to treat PTSD and bipolar disorder in rural areas showed ‘huge gains.’ Now comes the hard part

The Readout LOUD By Damian Garde, Meg Tirrell and Adam Feuerstein

Listen: Moderna v. NIH, psilocybin as a medicine, & the cultural intake of pharma CEOs

First Opinion By Erin Smith, Mark Heinemeyer and Harris A. Eyre

Preventing market failure in brain health: Moving toward fixes in investment, operations, and governance

First Opinion By Helena Roderick

Time, facial feminization, and the transgender experience

First Opinion By Gregg Martin

Hyperthymia: a mental illness that helped me for years — until it didn’t

First Opinion By Matthew Stefanko, Brea Perry and Anne Krendl

A new index measures the extent and depth of addiction stigma

Pharma By Olivia Goldhill

Latest psilocybin patent highlights the swirling battle over psychedelics intellectual property

recovery reentry disaster management lessons

First Opinion By Mary Meyer

Rebuilding the nation’s health care workforce during and after Covid-19: Lessons from disaster management

Health Tech By Katie Palmer

Most Read

The blind spots of blitzscaling in mental health tech

I work in a locked psychiatric ward. These days, you do too

Listen: Looking back on the first year of ‘First Opinion Podcast’

Health care workers’ suffering goes far beyond burnout. Self-care isn’t the cure

The pandemic didn’t increase suicides. That shouldn’t be a surprise

Largest psilocybin trial finds the psychedelic is effective in treating serious depression

‘Stuck in a cul-de-sac’: Researchers are finally breaking away from the central dogma of depression

First-of-its-kind study pits psilocybin against a common antidepressant

All Coverage

Jolting the brain’s circuits with electricity is moving from radical to almost mainstream therapy. Some crucial hurdles remain

We wish we’d written that: STAT staffers share their favorite stories of 2021

Deaths of despair: the unrecognized tragedy of working class immiseration

Three missing pieces the digital therapeutics sector needs to succeed in 2022

Listen: A parent on advocating for people with autism who can’t advocate for themselves

Many states aren’t ready for a 988 crisis line. The deadline is looming

As a Logic song topped the charts, helpline saw more calls and fewer suicides

Gatekeepers need to tame ‘Wild West’ of mental health and other digital health therapeutics

A decade without data: Eating disorder researchers say a gap in CDC survey has left them flying blind

STAT+ Conversation: The ‘Shroom Boom’

Stopping the spread of mass hysteria by Facebook, other social media platforms

Labels can harm, but they also can help: See ‘profound autism’

The pandemic forced an experiment in delivering intensive mental health care from home. Will the approach stick?

The pandemic has deeply affected many people with eating disorders

Talkspace’s leadership exodus leaves behind pressing questions — and a pile of cash

Why is the CDC missing in action on severe mental illnesses?

A telehealth effort to treat PTSD and bipolar disorder in rural areas showed ‘huge gains.’ Now comes the hard part

Listen: Moderna v. NIH, psilocybin as a medicine, & the cultural intake of pharma CEOs

Preventing market failure in brain health: Moving toward fixes in investment, operations, and governance

Time, facial feminization, and the transgender experience

Hyperthymia: a mental illness that helped me for years — until it didn’t

A new index measures the extent and depth of addiction stigma

Latest psilocybin patent highlights the swirling battle over psychedelics intellectual property

Rebuilding the nation’s health care workforce during and after Covid-19: Lessons from disaster management

Buoyed by its popular weight loss app, Noom enters the crowded field of digital mental health